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What are the differences in presentation of
candidates for percutaneous mitral commissurotomy
across the world and do they inﬂuence the results of
the procedure?
Les caractéristiques des patients candidats à une valvuloplastie mitrale
percutanée diffèrent-elles en fonction de leurs origines géographiques et
inﬂuent-elles sur le résultat immédiat de la procédure ?
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Summary
Background.— Despite marked global differences in the prevalence of rheumatic heart disease,
little is known about geographic variations in the characteristics of patients with severe mitral
stenosis.
Aim.— To determine if differences in rheumatic fever epidemiology inﬂuence the charac-
teristics of patients with mitral stenosis and the immediate results of percutaneous mitral
commissurotomy (PMC).
Methods.— We compared 350 patients (mean age: 41± 17 years, 81% women) scheduled for
PMC in ﬁve non-Western and two Western countries. Fifty consecutive patients were included
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MOTS CLÉS
Sténose mitrale ;
Rhumatisme
articulaire aigu ;
Commissurotomie
mitrale percutanée
dans les pays en voie de développement sont plus jeunes et présentent une sténose mitrale
plus sévère. Néanmoins, la CMP permet d’obtenir de bons résultats immédiats dans une même
proportion élevée de patients, ce qui témoigne des importantes possibilités d’utilisation de
cette technique à travers le monde.
© 2008 Elsevier Masson SAS. All rights reserved.
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SA body surface area
YHA New York Heart Association
MC percutaneous mitral commissurotomy
.D. standard deviation
ntroductionitral stenosis is almost invariably the result of rheumatic
ever, which is becoming less frequent in industrialized
ountries. However, mitral stenosis still accounts for more
han 10% of valvular heart diseases in Europe, in particular
a
[
a
w
mecause of immigrant populations [1]. Rheumatic heart
isease remains a public health problem in developing coun-
ries mainly due to the lack of medical prophylaxis and poor
iving conditions [2]. However, despite marked differences
n the prevalence of rheumatic heart disease across the
orld, little is known about geographic variations in the
haracteristics of patients with severe mitral stenosis and
heir potential consequences on the immediate results of
MC.
Since its introduction in the early 1980s, PMC has hadÉ. Marijon et al.
in each centre. All presented a mitral valve area less than 1.5 cm2 and were in New York Heart
Association (NYHA) functional class greater or equal to II, with no contraindications to PMC.
Results.— The 250 patients from non-Western countries were younger than the 100 patients
from Western countries (35± 12 vs 57± 15 years, p < 0.0001) and had more severe valve dis-
ease, assessed by indexed valve area (0.57± 0.14 vs 0.62± 0.14 cm2/m2 body surface area,
p = 0.006), mean gradient (15± 6 vs 8± 4mmHg, p < 0.0001) and systolic pulmonary artery pres-
sure (57± 21 vs 42± 14mmHg, p < 0.0001). PMC complication rates did not differ signiﬁcantly.
Good immediate PMC results were observed in 225 patients (90%) in non-Western and 88 (88%)
in Western centres (p = 0.58).
Conclusions.— Compared with Western countries, PMC candidates from non-Western countries
are younger, with more severe valve stenosis. However, PMC achieves good immediate results
in a similarly high proportion of patients, showing the wide applicability of this technique.
© 2008 Elsevier Masson SAS. All rights reserved.
Résumé
Contexte.— Malgré des différences importantes de prévalence du rhumatisme articulaire aigu
selon les pays concernés, les différences de caractéristiques des patients atteints de sténose
mitrale rhumatismale sont mal connues. L’objectif de cette étude était de déterminer dans
quelle mesure les différences épidémiologiques du rhumatisme articulaire aigu inﬂuencent les
caractéristiques des patients candidats à la commissurotomie mitrale percutanée (CMP), ainsi
que les résultats immédiats de la procédure.
Méthodes.— Cette étude a comparé 350 patients candidats à une CMP (âge moyen 41± 17 ans,
81 % femmes) inclus dans cinq centres situés dans des pays en voie de développement (Mozam-
bique, Tunisie, Polynésie franc¸aise, Vietnam et Brésil) et deux dans des pays industrialisés
(États-Unis et France). En décembre 2005, 50 patients consécutifs ont été inclus dans chaque
centre. Tous les patients présentaient une surface mitrale inférieure à 1,5 cm2, ils étaient
symptomatiques au moins en classe II de la NYHA et n’avaient pas de contre-indication à la
CMP.
Résultats.— Les 250 patients des pays en voie de développement étaient plus jeunes que les 100
patients des pays industrialisés (35± 12 vs 57± 15 ans, p < 0,0001) et présentaient une sténose
mitrale plus sévère selon la surface mitrale indexée (0,57± 0,14 cm2/m2 vs 0,62± 0,14 cm2/m2,
p = 0,006), le gradient moyen (15± 6mmHg vs 8± 4mmHg, p < 0,0001) et la pression pulmonaire
artérielle systolique (57± 21mmHg vs 42± 14mmHg, p < 0,0001). Le taux de complications de
la CMP ne différait pas. Un bon résultat immédiat de CMP a été obtenu chez 225 patients (90 %)
dans les pays en voie de développement et chez 88 (88 %) dans les pays industrialisés (p = 0,58).
Conclusions.— En comparaison avec les pays industrialisés, les patients candidats à une CMPsigniﬁcant impact on the treatment of mitral stenosis
3]. The successful results obtained with this technique, as
ssessed by observational and randomized series, explain
hy PMC has replaced surgical commissurotomy in the
ajority of cases [4—6].
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aWhat are the differences in presentation of candidates for P
The aim of this study was to test the hypothesis that
differences in the epidemiology of rheumatic fever may
inﬂuence the presentation of patients with mitral stenosis
and the results of PMC. To address this issue, we analysed
patient characteristics and the immediate results of PMC in
seven different centres located across the ﬁve continents to
compare the two Western with the ﬁve non-Western coun-
tries.
Materials and methods
Study population
At the end of 2005, we collected the characteristics of the
last 50 consecutive patients who underwent PMC in Boston
(USA), Maputo (Mozambique), Monastir (Tunisia), Papeete
(French Polynesia), Paris (France), Ho Chi Minh City (Viet
Nam) and São Paulo (Brazil). The choice of centres ensured
a wide range of geographical origins. All patients pre-
sented a mitral valve area of less than 1.5 cm2 and were
at least in NYHA functional class II. Contraindications to
the procedure were calciﬁcation of both commissures, left
atrial thrombus, mitral regurgitation grade greater than
2/4 and the coexistence of signiﬁcant aortic valve disease
[6].
Measurements and procedures
Two-dimensional transthoracic and transoesophageal
echocardiographic examinations were performed in the
same laboratory for each group by experienced operators on
the day preceding and 24 to 48 hours after the procedure.
All operators used the same predeﬁned methods to
assess the severity of mitral stenosis, regurgitation and
valve anatomy before, during and after the procedure. The
reference measurement for valve area was planimetry by
two-dimensional echocardiography. In the rare cases where
planimetry was not feasible, the Doppler pressure half-time
method was used instead. Mean mitral gradient was assessed
by continuous-wave Doppler. Mitral regurgitation was quan-
tiﬁed in four grades using colour Doppler. Systolic pulmonary
artery pressure was derived from the maximum gradient
between the right ventricle and atrium using continuous-
wave Doppler. Morphologic evaluation of the valve was done
using the Wilkins score [7]. Balloon commissurotomy was
performed by experienced operators, using the Inoue tech-
nique in 315 (90.0%) cases, a double-balloon (9.7%) in 34
cases and a metallic commissurotome in one (0.3%) case.
With the Inoue technique, balloon size was chosen accord-
ing to the patient height and the procedure used stepwise
inﬂations under echocardiographic guidance. Criteria for
ending the procedure were complete opening of at least one
commissure with a valve area greater or equal to 1.5 cm2,
or greater or equal to 1.0 cm2/m2 of BSA, or the appearance
or increase of regurgitation greater than 1/4 [6].
Good immediate results were deﬁned as valve area
2greater or equal to 1.5 cm , or greater or equal to
1.0 cm2/m2 BSA without mitral regurgitation greater than
2/4. Complications analysed were in-hospital death, mitral
regurgitation greater than 2/4, cardiac tamponade and the
need for surgery within the ﬁrst month.
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tatistical analysis
uantitative variables were described as mean± S.D. Com-
arisons used analysis of variance for quantitative variables
nd the Chi-square test for qualitative variables. We com-
ared 13 baseline preprocedure variables (Table 1) and eight
ostprocedure variables linked to the immediate results of
MC (Table 2). Patient characteristics and immediate results
f PMC were ﬁrst compared between Western (USA and
rance) and non-Western countries (Mozambique, Tunisia,
rench Polynesia, Viet Nam and Brazil). In the second part
f the analysis, patient characteristics and the results of
MC were compared between the seven centres.
All tests were two-sided. A p-value was considered sig-
iﬁcant when less than 0.05. Analysis was performed with
AS statistical software (SAS Institute Inc., release 8.2).
esults
he mean age of the 350 patients was 41± 17 years (range:
1—89) and 283 (81%) were women. Seventeen patients (5%)
ere aged less than 18 years; all of these patients were
reated in non-Western countries. Fifty-ﬁve patients (16%)
ad undergone at least one procedure of commissurotomy
reviously, which was, either singly or in combination: PMC
n = 36); open-heart commissurotomy (n = 15); and closed-
eart commissurotomy (n = 7).
Comparisons between the ﬁve non-Western and the two
estern countries are reported in Tables 1 and 2. Candi-
ates for PMC from non-Western nations were younger, in
lower NYHA class and had less frequent atrial ﬁbrillation
han those from Western countries. This was in contrast with
more severe valvular disease, as shown consistently by a
maller indexed mitral valve area, higher mean mitral gra-
ient and higher systolic artery pulmonary pressure. There
ere no signiﬁcant differences concerning overall mitral
alve anatomy, as assessed by the Wilkins score. Good imme-
iate results were observed in 225 patients (90%) from
on-Western centres and in 88 (88%) from Western centres
p = 0.58). No signiﬁcant differences were found regarding
omplication rates between non-Western and Western coun-
ries.
Baseline characteristics and immediate results of the 350
atients in the seven centres are detailed in Tables 3 and 4.
ost patient characteristics differed signiﬁcantly between
he seven centres. There were no signiﬁcant differences in
he frequency of complications from PMC. The difference
etween the frequency of good immediate results from PMC
as of borderline signiﬁcance (p = 0.05).
iscussion
his series is the ﬁrst enabling the contemporary spectrum
f mitral stenosis to be assessed worldwide. Although it is
dmitted that the presentation of rheumatic heart disease
aries across countries, differences in patients’ character-
stics and their impact on the results of interventions have
ot been investigated using a homogeneous approach. Our
tudy shows that mitral stenosis is more severe and occurs in
ounger patients in areas where rheumatic heart disease is
614 É. Marijon et al.
Table 1 Baseline characteristics before percutaneous mitral commissurotomy in patients from non-Western and Western
countries.
Non-Western countries
(n = 250) mean± S.D. or n (%)
Western countries (n = 100)
mean± S.D. or n (%)
p
Age (years) 35± 12 57± 15 <0.0001
Women 201 (80) 82 (82) 0.73
Previous commissurotomy 39 (16) 16 (16) 0.92
Previous embolism 19 (8) 20 (20) 0.009
Ongoing pregnancy 16 (6) 2 (2) 0.09
NYHA III or IV 121 (48) 63 (63) 0.01
Body surface area (m2) 1.60± 0.23 1.72± 0.18 <0.0001
Wilkins score 8.8± 1.4 8.6± 2.0 0.35
Atrial ﬁbrillation 40 (16) 45 (45) <0.0001
Systolic pulmonary artery pressure (mmHg) 57± 21 42± 14 <0.0001
Mean mitral gradient (mmHg) 15± 6 8± 4 <0.0001
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tMitral valve area (cm2) 0.91± 0.23
Indexed mitral valve area (cm2/m2 BSA) 0.57± 0.14
till common. Despite these differences, PMC is an effective
reatment of mitral stenosis worldwide.
According to the latest World Health Organization report
8], rheumatic heart disease remains a major cause of
ortality in developing countries, with more than 230,000
nnual directly attributable deaths and a high level of mor-
idity, with at least 15million estimated cases of rheumatic
eart disease [8,9]. In addition, the prevalence of rheumatic
ever is likely to be underestimated from clinical ﬁndings,
s shown by the use of systematic echocardiographic exami-
ations [10]. The younger age found among the non-Western
opulation is one of the most signiﬁcant indications that
heumatic heart disease is more severe in areas where
are penicillin use and living conditions promote strepto-
occus transmission. More frequent and/or more severe
cute rheumatic fever attacks, resulting in an exaggerated
mmune response to speciﬁc bacterial epitopes in a suscep-
ible host, may explain the earlier and more severe form
f the disease. Conversely, the decrease in the incidence of
heumatic fever in industrialized countries resulted not only
n a decrease in the prevalence of rheumatic heart disease
ut also in an occurrence at an older age. The comparison
etween series of surgical commissurotomy performed in
he 1950s and 1960s in the USA and in Europe and recent
o
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Table 2 Immediate results and complications of percutaneou
Western countries.
Non-Western count
(n = 250) mean± S.D
Mitral valve area (cm2) 1.91± 0.36
Indexed mitral valve area (cm2/m2
body surface area)
1.22± 0.27
In-hospital cardiac death 2 (0.8)
Mitral regurgitation≥3/4 7 (2.8)
Embolism 2 (0.8)
Cardiac tamponade 4 (1.6)
Surgery within 30 days 8 (3.2)
Good immediate results 225 (90.0)1.05± 0.22 <0.0001
0.62± 0.14 0.006
eries of PMC shows an increase in the mean age of patient
andidates for surgical or percutaneous mitral commissuro-
omy [11,12]. The only characteristic that did not differ
etween the groups was the constant female predominance,
hich is well-known in mitral stenosis but not explained
learly. This may raise again the hypothesis of a genetic
redisposition or susceptibility to rheumatic fever [8,13].
In our study, patients from non-Western countries had
ore severe mitral stenosis. Although the difference was of
maller magnitude with indexed rather than absolute valve
rea, other indices of severity (mean mitral gradient and sys-
olic pulmonary artery pressure) were consistently higher in
atients from non-Western countries. Although the degree
f mitral stenosis and its haemodynamic consequences were
ore severe in patients of non-Western origin, they pre-
ented with lower NYHA class, which may be related in part
o the younger age and the lower prevalence of atrial ﬁbril-
ation in patients from non-Western countries [14]. However,
t is also necessary to take into account the subjectivity of
he assessment of the severity of dyspnoea in the absence
f standardized evaluation at exercise.
Although mitral stenosis is the consequence of rheumatic
ever, anatomical lesions may differ according to the
eographic origin. In particular, valve calciﬁcation is
s mitral commissurotomy in patients from non-Western or
ries
. or n (%)
Western countries (n = 100)
mean± S.D. or n (%)
p
1.84± 0.46 0.14
1.08± 0.29 <0.0001
1 (1.0) 0.85
5 (5.0) 0.31
2 (2.0) 0.21
0 0.47
4 (4.0) 0.71
88 (88.0) 0.58
W
hat
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the
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candidates
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Table 3 Baseline characteristics of the 350 patients before percutaneous mitral commissurotomy.
Boston (n = 50)
mean± S.D. or
n (%)
Maputo (n = 50)
mean± S.D. or
n (%)
Monastir (n = 50)
mean± S.D. or n
(%)
Papeete (n = 50)
mean± S.D. or n
(%)
Paris (n = 50)
mean± S.D. or n
(%)
Ho Chi Minh (n = 50)
mean± S.D. or n (%)
São Paulo (n = 50)
mean± S.D. or n
(%)
p
Age (years) 58± 17 28± 11 36± 13 32± 11 57± 13 39± 9 40± 14 <0.0001
Women 45 (90) 39 (78) 43 (86) 40 (80) 37 (74) 37 (74) 42 (84) 0.30
Previous
commissurotomy
4 (8) 5 (10) 9 (18) 13 (26) 12 (24) 0 12 (24) 0.001
Previous embolism 10 (20) 4 (8) 5 (10) 3 (6) 10 (20) 7 (14) 0 0.01
Pregnancy 1 (2) 1 (2) 7 (14) 3 (6) 1 (2) 2 (4) 3 (6) 0.08
NYHA III or IV 35 (70) 40 (80) 24 (48) 12 (24) 28 (56) 24 (48) 21 (42) <0.0001
Body surface area
(m2)
1.71± 0.16 1.50± 0.18 1.56± 0.22 1.87± 0.22 1.73± 0.19 1.45± 0.09 1.63± 0.18 <0.0001
Wilkins score 7.8± 1.9 8.7± 1.6 8.7± 1.0 8.7± 1.8 9.4± 2.1 8.9± 1.1 8.8± 0.9 0.02
Atrial ﬁbrillation 28 (56) 7 (14) 13 (26) 1 (2) 17 (34) 9 (18) 10 (20) <0.0001
Systolic pulmonary
artery pressure
(mmHg)
39± 14 65± 25 46± 12 46± 10 46± 14 65± 21 63± 23 <0.0001
Mean mitral
gradient (mmHg)
8± 4 16± 5 16± 6 10± 4 8± 4 15± 5 18± 8 <0.0001
Mitral valve area
(cm2)
1.02± 0.24 0.74± 0.23 1.04± 0.20 1.06± 0.20 1.08± 0.14 0.80± 0.17 0.89± 0.18 <0.0001
Indexed mitral valve
area (cm2/m2
BSA)
0.60± 0.15 0.50± 0.16 0.67± 0.13 0.58± 0.13 0.63± 0.12 0.55± 0.11 0.55± 0.11 <0.0001
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ncountered more frequently in old patients from Western
ountries [14]. The absence of difference in the Wilkins
core between Western and non-Western countries in our
tudy might be explained by the fact that more frequent
alciﬁcation in Western countries may be compensated for
y more severe impairment of subvalvular apparatus in
on-Western countries. However, several reports emphasize
hat signiﬁcant subvalvular deformity cannot be used as
he unique predictive factor of immediate results of PMC
15—17].
There were no signiﬁcant differences in complication
ates after PMC between the patients from non-Western and
estern countries. Severe mitral regurgitation results fre-
uently from non-commissural leaﬂet tearing; it is the most
requent complication of the procedure and is not related
losely to patient characteristics. Other complication rates
re known to be related mainly to the experience of oper-
tors [18]. The absence of difference in complication rates
ay be explained by the fact that all procedures in the seven
entres were performed by experienced operators, thereby
imiting bias inherent to the learning curve.
Despite marked differences in patient characteristics,
here were no signiﬁcant differences in the success rate
f PMC between Western and non-Western countries. This
llustrates that the prediction of immediate results of PMC
s multifactorial and does not rely solely on valve anatomy
ut also on clinical factors, age and consequences of valve
isease [15—17,19]. Pulmonary artery hypertension, small
itral valve area and high gradient have been described as
redictors of poor immediate results of the procedure and
ere encountered more frequently in non-Western countries
20]. However, this may be compensated for by the older age
nd the more frequent atrial ﬁbrillation in Western coun-
ries, which have also been identiﬁed as predictive of poor
esults of PMC [15].
PMC seems to give a higher increase in valve area in
atients from non-Western countries. This trend is found in
he literature when comparing the results of large published
eries from Western [17,21] and non-Western countries
22—24].
The composite endpoint of good immediate results used
n our study takes into account the two main phenomena
hat may require mitral surgery, that is insufﬁcient valve
pening and the occurrence of severe mitral regurgitation.
mitral valve greater or equal to 1.5 cm2 generally provides
ormal haemodynamic conditions and leads to a persistent
unctional improvement. This threshold has therefore been
sed in most studies. We also considered an indexed valve
rea greater or equal to 1.0 cm2/m2 BSA to be a good result.
he rationale was to avoid considering patients of small
ody size, who had a post-PMC valve area less than 1.5 cm2
ut greater or equal to 1.0 cm2/m2 BSA, as having a poor
mmediate result from PMC. The difference in body size of
atients from non-Western—particularly Asian— countries
nd the proportion of young patients (4.9% of all patients
nd 6.8% of the non-Western population were aged less than
8 years) justify the use of an indexed valve area, even if no
ndexed threshold is established for mitral stenosis.
This study shows that a number of patients with non-ideal
natomical conditions derived beneﬁt from PMC as the initial
reatment. Surgery was used in case of failure of PMC rather
han as a ﬁrst-line treatment in these cases [18]. Moreover,
MC
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[What are the differences in presentation of candidates for P
a number of patients from non-Western countries presented
with high pulmonary pressure and were therefore at high
risk for surgery, which can be a further incentive for the use
of a percutaneous procedure as a ﬁrst-line treatment.
Study limitations
Differences in healthcare systems between countries may
account for a referral bias. However, the younger age of
patients from non-Western countries shows that the higher
severity of mitral stenosis cannot be explained by late refer-
ral.
Certain patients undergoing PMC in Western areas are
immigrants from non-Western countries. Therefore, classi-
fying patients in terms of their ethnic origin rather than
their country of residence would probably lead to even more
marked differences.
Different components of the Wilkins score (leaﬂet mobil-
ity, valvular thickening, subvalvular thickening and valvular
calciﬁcation) were not analysed in this series. Thus, it was
not possible to compare in detail the anatomical impairment
of the different components of the mitral apparatus.
Nevertheless, the strength of this series was the inclu-
sion of consecutive patients from a wide range of centres
during the same period, using the Inoue technique in 90%
of cases. Thus, our results are likely to reﬂect the con-
temporary presentation of patient candidates for PMC.
Larger single-centre series have been reported in numerous
countries. However, they covered long time periods during
which changes occurred in patient selection and technique.
This heterogeneity precludes valid comparisons being made
between different series to assess the relationship between
the differences in patient characteristics and the results of
PMC.
Conclusion
Compared with patients from Western countries, candidates
for PMC from non-Western countries are younger, have more
severe valve stenosis and pulmonary hypertension, but a
lower frequency of atrial ﬁbrillation and previous embolism.
Despite marked differences, PMC achieves good immedi-
ate results in a similarly high proportion of patients from
different geographical areas, further illustrating the wide
applicability of this technique.
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